for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Mizuho Medy Co Ltd

4595.T

Latest Trade

2,413.00JPY

Change

-11.00(-0.45%)

Volume

12,900

Today's Range

2,398.00

 - 

2,431.00

52 Week Range

1,694.00

 - 

3,200.00

As of on the Tokyo Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
2,424.00
Open
2,403.00
Volume
12,900
3M AVG Volume
0.55
Today's High
2,431.00
Today's Low
2,398.00
52 Week High
3,200.00
52 Week Low
1,694.00
Shares Out (MIL)
9.52
Market Cap (MIL)
22,985.27
Forward P/E
23.94
Dividend (Yield %)
1.20

Next Event

Q3 2019 Mizuho Medy Co Ltd Earnings Release

Latest Developments

More

Mizuho Medy says listing on TSE Second Section

Mizuho Medy says upgrade of stock listing

Mizuho Medy completes off-floor distribution

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Mizuho Medy Co Ltd

MIZUHO MEDY CO., LTD. is a Japan-based company principally engaged in-vitro diagnostic pharmaceuticals business. The Company mainly provides in-vitro diagnostic pharmaceuticals, including immune serum test drugs, biochemical test drugs, urine and feces test drugs, microbial test drugs, blood test drugs, pathological test drugs and others, in hospital and medical practitioner fields. In addition, the Company also provides over-the-counter (OTC) drugs to pharmacies and drug stores, and sells fruit tree virus test drugs to which they apply the technology of immune serology test to agricultural test centers.

Industry

Biotechnology & Drugs

Contact Info

5-4, Fujinoki-machi

+81.942.850303

https://www.mizuho-m.co.jp/

Executive Leadership

Fuminari Karakawa

Chairman of the Board, President, Representative Director

Masashi Imamura

Managing Director, Director of Development Planning

Toshio Kambara

Chief Director of Sales, Director of Overseas Business, Director

Takahiro Furuno

Executive Officer, Director of Manufacturing

Nobuhiro Uto

Executive Officer, Director of General Affairs

Key Stats

1.00 mean rating - 1 analysts
Sell
Hold
Buy
Price To Earnings (TTM)
28.91
Price To Sales (TTM)
3.72
Price To Book (MRQ)
7.20
Price To Cash Flow (TTM)
24.98
Total Debt To Equity (MRQ)
11.34
LT Debt To Equity (MRQ)
0.00
Return on Investment (TTM)
21.60
Return on Equity (TTM)
16.14

Latest News

BRIEF-Mizuho Medy obtains marketing and manufacture approval of mycoplasma nucleic acid kit for genetic POCT examination

* Says it obtained the marketing and manufacture approval of mycoplasma nucleic acid kit for genetic POCT examination in Japan on Feb. 19

BRIEF- Mizuho Medy to acquire property for 282.8 mln yen

* Says it plans to acquire Fukuoka-based land for 282.8 million yen

BRIEF-Mizuho Medy completes off-floor distribution

* Says it completed the off-floor distribution of shares on July 20

BRIEF-Mizuho Medy to offer off-floor distribution of shares

* Says it will offer an off-floor distribution of 100,000 shares of its stock at the price of 2,845 yen per share, on the Tokyo Stock Exchange, on July 20

BRIEF-Mizuho Medy to offer off-floor distribution of shares

* Says it will offer an off-floor distribution of 100,000 shares on Tokyo Stock Exchange, from July 20 to July 25

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up